BioCentury
ARTICLE | Company News

Management tracks: Anthem, Aimmune

November 6, 2017 11:40 PM UTC

Anthem Inc. (NYSE:ANTM) said President and CEO Joseph Swedish will step down, effective Nov. 17. He will continue to serve as executive chairman until May 2018 and as senior adviser through May 2020. He is succeeded by Gail Boudreaux, who had been CEO of the United HealthCare subsidiary of UnitedHealth Group Inc. (NYSE:UNH).

Aimmune Therapeutics Inc. (NASDAQ:AIMT) said CEO Stephen Dilly will retire, effective YE18. The allergy company is seeking a replacement for Dilly, who has been CEO since 2014...